Canadians file class action lawsuit against antidepressant drug maker

Email this article to a friend

Printable Version

Articles Related to This Article: • Antidepressant drug causes liver failure, kills patients, but FDA refuses to issue ban • The FDA Exposed: An Interview With Dr. David Graham, the Vioxx Whistleblower • Mercury Fillings Shattered! FDA, ADA Conspiracy to Poison Children with Toxic Mercury Fillings Exposed in Groundbreaking Lawsuit Sign the Health Revolution Petition Join the call for genuine health freedom in America. End FDA tyranny and Big Pharma corruption. Watch the video and sign the petition here.

Serzone, one of several dangerous antidepressant drugs now available on the market, has killed dozens of patients and injured many more. In Canada, citizens are joining a class action lawsuit against the drug maker. In the U.S., the FDA still refuses to ban Serzone.

As well described on ADrugRecall.com, "Public Citizen consumer group petitioned the FDA to ban Serzone in March 2003. When the FDA failed to adequately respond to the group's request, they renewed its' call for the FDA to ban the antidepressant in October 2003. While Canadian officials announced they would ban Serzone because of its risks, critics of the U.S. agency wondered why the FDA had not made similar actions. When the World Health Organization and Health Canada compared different antidepressant drugs, Serzone was the only one displaying increased risks for serious liver injury. The influence rich and powerful drug companies have over federal regulation has been questioned over the years. Serzone's allowance to remain on the market is yet another example of controversial safety regulating."
About the author: Mike Adams is a natural health author and technology pioneer with a strong interest in personal health, the environment and the power of nature to help us all heal He has authored and published thousands of articles, interviews, consumers guides, and books on topics like health and the environment, reaching millions of readers with information that is saving lives and improving personal health around the world. Adams is a trusted, independent journalist who receives no money or promotional fees whatsoever to write about other companies' products. In 2007, Adams launched EcoLEDs, a maker of energy efficient LED lights that greatly reduce CO2 emissions. He's also a noted technology pioneer and founded a software company in 1993 that developed the HTML email newsletter software currently powering the NaturalNews subscriptions. Adams is currently the executive director of the Consumer Wellness Center, a 501(c)3 non-profit, and pursues hobbies such as Pilates, Capoeira, nature macrophotography and organic gardening. Known on the 'net as 'the Health Ranger,' Adams shares his ethics, mission statements and personal health statistics at www.HealthRanger.org


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Antidepressant drug causes liver failure, kills patients, but FDA refuses to issue ban • The FDA Exposed: An Interview With Dr. David Graham, the Vioxx Whistleblower • Mercury Fillings Shattered! FDA, ADA Conspiracy to Poison Children with Toxic Mercury Fillings Exposed in Groundbreaking Lawsuit	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/000373_Serzone_the_FDA_class_action_lawsuit.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/000373_Serzone_the_FDA_class_action_lawsuit.html">Canadians file class action lawsuit against antidepressant drug maker</a>